Axsome Therapeutics, Inc.
AXSM
Revenue
118.77M
▲14.00M▲13.37%
3 Months ChangeAssets
568.50M
▲7.04M▲1.25%
3 Months ChangeLiabilities
511.48M
▲42.92M▲9.16%
3 Months ChangeFree Cash Flow
-53.57M
▼-47.67M▼-809.11%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-01
Form 8-K
ID: 0000950170-24-110957
2024-09-04
Form 8-K
ID: 0000950170-24-103098
2024-08-21
Form 8-K
ID: 0000950170-24-099389
2024-08-05
Form 10-Q
ID: 0000950170-24-090828
2024-08-05
Form 8-K
ID: 0000950170-24-090311
2024-06-11
Form 8-K
ID: 0000950170-24-071960
2024-06-05
Form 8-K
ID: 0000950170-24-069077
2024-05-06
Form 10-Q
ID: 0000950170-24-053697
2024-05-06
Form 8-K
ID: 0000950170-24-053197
2024-04-01
Form 8-K
ID: 0000950170-24-038894